CORRELATION OF SERUM SEMAPHORIN 3A WITH DISEASE ACTIVITY IN ANKYLOSING SPONDYLITIS PATIENTS
Abd Elhady, A., Mohamed, Y., Elsaid, H., Ismail, F. (2021). CORRELATION OF SERUM SEMAPHORIN 3A WITH DISEASE ACTIVITY IN ANKYLOSING SPONDYLITIS PATIENTS. EKB Journal Management System, 27(3), 447-454. doi: 10.21608/zumj.2019.15661.1402
Adlia Mohamed Abd Elhady; Yassir Abd El Hai Mohamed; Hanaa H Elsaid; Fatma Elzahraa Mohamed Ismail. "CORRELATION OF SERUM SEMAPHORIN 3A WITH DISEASE ACTIVITY IN ANKYLOSING SPONDYLITIS PATIENTS". EKB Journal Management System, 27, 3, 2021, 447-454. doi: 10.21608/zumj.2019.15661.1402
Abd Elhady, A., Mohamed, Y., Elsaid, H., Ismail, F. (2021). 'CORRELATION OF SERUM SEMAPHORIN 3A WITH DISEASE ACTIVITY IN ANKYLOSING SPONDYLITIS PATIENTS', EKB Journal Management System, 27(3), pp. 447-454. doi: 10.21608/zumj.2019.15661.1402
Abd Elhady, A., Mohamed, Y., Elsaid, H., Ismail, F. CORRELATION OF SERUM SEMAPHORIN 3A WITH DISEASE ACTIVITY IN ANKYLOSING SPONDYLITIS PATIENTS. EKB Journal Management System, 2021; 27(3): 447-454. doi: 10.21608/zumj.2019.15661.1402

CORRELATION OF SERUM SEMAPHORIN 3A WITH DISEASE ACTIVITY IN ANKYLOSING SPONDYLITIS PATIENTS

Zagazig University Medical Journal
Article 201, Volume 27, Issue 3, May 2021, Page 447-454  XML PDF (595.54 K)
Document Type: Original Article
DOI: 10.21608/zumj.2019.15661.1402
View on SCiNiTO View on SCiNiTO
Authors
Adlia Mohamed Abd Elhady1; Yassir Abd El Hai Mohamed1; Hanaa H Elsaid2; Fatma Elzahraa Mohamed Ismail email 1
1Rheumatology and Rehabilitation Department,Faculty of Medicine, Zagazig University, Egypt
2Clinical Pathology Department, Faculty of Medicine, Zagazig University, Egypt
Abstract
Objective: To assess the serum level of Semaphorin 3A in ankylosing spondylitis (AS) patients and to assess its correlation with disease activity.
Subjects and Methods: The study was carried on 40 subjects, 20 AS patients (12 males and 8 females) fulfilled the 1984 Modified New York criteria for diagnosis of ankylosing spondylitis, and 20 healthy subjects, taken as control group (12 females and 8 males). A consent was taken from all subjects to share in the study. Disease Activity Score (ASDAS) was calculated for AS patients and functional assessment was done using the Bath Ankylosing Spondylitis Functional Index (BASFI).
Results: Serum levels of Semaphorin 3A were significantly higher(P
Keywords
Ankylosing spondylitis; Semaphorin 3A; biomarker
Statistics
Article View: 289
PDF Download: 249